[go: up one dir, main page]

NO20024623L - Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform - Google Patents

Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform

Info

Publication number
NO20024623L
NO20024623L NO20024623A NO20024623A NO20024623L NO 20024623 L NO20024623 L NO 20024623L NO 20024623 A NO20024623 A NO 20024623A NO 20024623 A NO20024623 A NO 20024623A NO 20024623 L NO20024623 L NO 20024623L
Authority
NO
Norway
Prior art keywords
preparation
crystal form
novel process
new crystal
imidazopyridine derivative
Prior art date
Application number
NO20024623A
Other languages
English (en)
Other versions
NO20024623D0 (no
Inventor
Fumihiko Matsubara
Takashi Ohya
Masaaki Uenaka
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO20024623D0 publication Critical patent/NO20024623D0/no
Publication of NO20024623L publication Critical patent/NO20024623L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20024623A 2000-03-30 2002-09-26 Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform NO20024623L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000092565 2000-03-30
PCT/JP2001/002620 WO2001074821A1 (en) 2000-03-30 2001-03-29 Novel process for producing fused imidazopyridine derivative and novel crystal form

Publications (2)

Publication Number Publication Date
NO20024623D0 NO20024623D0 (no) 2002-09-26
NO20024623L true NO20024623L (no) 2002-11-08

Family

ID=18607880

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024623A NO20024623L (no) 2000-03-30 2002-09-26 Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform

Country Status (17)

Country Link
US (1) US7049437B2 (no)
EP (1) EP1270578A4 (no)
JP (1) JP3481930B2 (no)
KR (1) KR20020082898A (no)
CN (1) CN1203073C (no)
AU (1) AU2001244613A1 (no)
BR (1) BR0109643A (no)
CA (1) CA2403131A1 (no)
CZ (1) CZ20023276A3 (no)
HK (1) HK1054387A1 (no)
HU (1) HUP0300580A3 (no)
IL (1) IL151877A0 (no)
MX (1) MXPA02009460A (no)
NO (1) NO20024623L (no)
PL (1) PL357672A1 (no)
WO (1) WO2001074821A1 (no)
ZA (1) ZA200207295B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1408041A4 (en) 2001-07-16 2005-08-17 Shionogi & Co PROCESS FOR THE PREPARATION OF AMIDINE DERIVATIVES
JPWO2004078173A1 (ja) * 2003-02-05 2006-06-08 塩野義製薬株式会社 溶出性の改善された錠剤
US7648997B2 (en) 2003-08-12 2010-01-19 Coley Pharmaceutical Group, Inc. Hydroxylamine substituted imidazoquinolines
EP1658076B1 (en) 2003-08-27 2013-03-06 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
EP1660026A4 (en) 2003-09-05 2008-07-16 3M Innovative Properties Co TREATMENT FOR CD5 + B CELL LYMPHOMA
NZ546273A (en) 2003-10-03 2009-05-31 Coley Pharm Group Inc Alkoxy substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
AU2004291101A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
CA2545825A1 (en) * 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
AR046781A1 (es) 2003-11-25 2005-12-21 3M Innovative Properties Co Derivados de imidazoquinolinas. composiciones farmaceuticas.
EP1701955A1 (en) 2003-12-29 2006-09-20 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
WO2005066169A2 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
EP1730143A2 (en) 2004-03-24 2006-12-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
CN1960700A (zh) * 2004-03-30 2007-05-09 荷兰联合利华有限公司 含维生素和类黄酮的亮肤组合物
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006009832A1 (en) * 2004-06-18 2006-01-26 3M Innovative Properties Company Substituted imidazo ring systems and methods
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US8034938B2 (en) 2004-12-30 2011-10-11 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
CA2592904C (en) 2004-12-30 2015-04-07 3M Innovative Properties Company Chiral fused [1,2]imidazo[4,5-c] ring compounds
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
CA2597587A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
WO2006107851A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
JP2008535832A (ja) 2005-04-01 2008-09-04 コーリー ファーマシューティカル グループ，インコーポレイテッド ピラゾロピリジン−１，４−ジアミン、およびそのアナログ
CA2623541A1 (en) * 2005-09-23 2007-03-29 Coley Pharmaceutical Group, Inc. Method for 1h-imidazo[4,5-c]pyridines and analogs thereof
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
EP3856341B1 (en) * 2019-04-12 2023-09-06 Blueprint Medicines Corporation Crystalline forms of (s)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1h-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378848A (en) 1992-02-12 1995-01-03 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
US5658903A (en) * 1995-06-07 1997-08-19 Smithkline Beecham Corporation Imidazole compounds, compositions and use

Also Published As

Publication number Publication date
ZA200207295B (en) 2003-09-11
US20030088102A1 (en) 2003-05-08
JP3481930B2 (ja) 2003-12-22
HK1054387A1 (zh) 2003-11-28
NO20024623D0 (no) 2002-09-26
IL151877A0 (en) 2003-04-10
CN1419557A (zh) 2003-05-21
KR20020082898A (ko) 2002-10-31
WO2001074821A1 (en) 2001-10-11
HUP0300580A3 (en) 2006-06-28
US7049437B2 (en) 2006-05-23
HUP0300580A2 (hu) 2003-07-28
PL357672A1 (en) 2004-07-26
MXPA02009460A (es) 2003-02-12
BR0109643A (pt) 2003-04-22
CN1203073C (zh) 2005-05-25
CA2403131A1 (en) 2001-10-11
AU2001244613A1 (en) 2001-10-15
EP1270578A4 (en) 2004-11-03
EP1270578A1 (en) 2003-01-02
CZ20023276A3 (cs) 2003-02-12

Similar Documents

Publication Publication Date Title
NO20024623L (no) Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform
NO20030844D0 (no) Fremgangsmåte for fremstilling av N-aryl-antranilinsyrer og derivater derav
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20031694D0 (no) Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament
NO20022176D0 (no) Absorberende gjenstand og fremgangsmåte for fremstilling av denne
NO20032518L (no) Fremgangsmåte for fremstilling av amlodipinmaleat
CY2009001I2 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
NO20013942L (no) Fremgangsmate for fremstilling av Citalopram
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20023950L (no) Fremgangsmåte for fremstilling av en titanholdig zeolitt
NO20024321D0 (no) Fremgangsmåte for fremstilling av krystallinsk form I av kabergolin
NO20003555L (no) Fremgangsmåte ved fremstilling av konstruksjonselementer og de resulterende elementer
NO20021124D0 (no) Fremgangsmåte for fremstilling av benzoksazinderivater og mellomprodukter derfor
NO20031413L (no) Ny fremgangsmate for fremstilling av oksabispidiner og nytt mellomprodukt
NO20025069D0 (no) Ny stabil krystall av tiazolidindionderivat og fremgangsmÕte for fremstilling av det samme
NO20025423L (no) Fremgangsmate for fremstilling av Citalopram
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
NO20023973D0 (no) Fremgangsmåte for fremstilling av en titanholdig zeolitt
NO20021118D0 (no) Fremgangsmåte for fremstilling av citalopram
NO20023577L (no) Fremgangsmåte for fremstilling av acetyl-amidinofenylalanyl- cykloheksylglycyl-pyridinioalaninamider
NO20030587D0 (no) Fremgangsmåte til fremstilling av diskodermolid og analoger derav
NO20023702D0 (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20032297L (no) Fremgangsmåte for fremstilling av distamycinderivater
NO20025385D0 (no) FremgangsmÕte for fremstilling av sulfonylbenzoylguanidiniumsalter
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application